COVID-19 endocrinopathy with hindsight from SARS.
Am J Physiol Endocrinol Metab
; 320(1): E139-E150, 2021 01 01.
Article
in English
| MEDLINE | ID: covidwho-945025
ABSTRACT
The current COVID-19 pandemic is probably the worst the world has ever faced since the start of the new millennium. Although the respiratory system is the most prominent target of SARS-CoV-2 (the contagion of COVID-19), extrapulmonary involvement are emerging as important contributors of its morbidity and lethality. This article summarizes the impact of SARS-CoV and SARS-CoV-2 on the endocrine system to facilitate our understanding of the nature of coronavirus-associated endocrinopathy. Although new data are rapidly accumulating on this novel infection, many of the endocrine manifestations of COVID-19 remain incompletely elucidated. We, hereby, summarize various endocrine dysfunctions including coronavirus-induced new onset diabetes mellitus, hypocortisolism, thyroid hormone, and reproductive system aberrations so that clinicians armed with such insights can potentially benefit patients with COVID-19 at the bedside.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Endocrine System Diseases
/
COVID-19
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Am J Physiol Endocrinol Metab
Journal subject:
Endocrinology
/
Physiology
/
Metabolism
Year:
2021
Document Type:
Article
Affiliation country:
Ajpendo.00480.2020
Similar
MEDLINE
...
LILACS
LIS